| Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis (NCT05061446) | Pfizer | 2021-09-10 |
| Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma (NCT04782687) | US Oncology Research | 2021-09-10 |
| Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 (NCT04615871) | Vladimír Džavík | 2021-09-10 |
| A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer (NCT04787289) | British Columbia Cancer Agency | 2021-09-10 |
| HAT for the Treatment of Sepsis Associated With NASTI (NCT05157360) | Ascension Health | 2021-09-10 |
| The Impact of Exercise / Stress Stimuli on HMB Supplementation Efficacy (NCT05444959) | Poznan University of Physical Education | 2021-09-10 |
| Dupilumab_Metastatic NSCLC (NCT05013450) | Thomas Marron | 2021-09-10 |
| A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS). (NCT04729751) | Mirum Pharmaceuticals, Inc. | 2021-09-09 |
| A Single and Repeat Dose Trial in Participants With Hepatic Impairment (NCT05009680) | Galecto Biotech AB | 2021-09-09 |
| Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease (NCT04691661) | Il-Yang Pharm. Co., Ltd. | 2021-09-09 |
| A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer (NCT05156424) | Kira Murphy | 2021-09-09 |
| Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA) (NCT04661033) | Sanofi | 2021-09-09 |
| A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents (NCT05094804) | OncoResponse, Inc. | 2021-09-09 |
| An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber (NCT05102409) | Aldeyra Therapeutics, Inc. | 2021-09-09 |
| Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma (NCT04535271) | Sarcoma Oncology Research Center, LLC | 2021-09-09 |
| A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection (NCT05047601) | Pfizer | 2021-09-09 |
| Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer (NCT04989283) | National Cancer Institute (NCI) | 2021-09-09 |
| A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 (NCT04972968) | AbbVie | 2021-09-09 |
| Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis (NCT05018806) | Sanofi | 2021-09-09 |
| A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. (NCT05016323) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-09 |
| Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin (NCT05038982) | Johns Hopkins University | 2021-09-09 |
| Copanlisib Plus Venetoclax in R/R DLBCL (NCT04572763) | Dana-Farber Cancer Institute | 2021-09-08 |
| A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies (NCT04927884) | ImmunityBio, Inc. | 2021-09-08 |
| ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer (NCT04986423) | Zenith Epigenetics | 2021-09-08 |
| Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children (NCT04586504) | Columbia University | 2021-09-08 |
| Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) (NCT04937907) | Shanghai Children's Hospital | 2021-09-08 |
| Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma (NCT04946318) | Novartis Pharmaceuticals | 2021-09-08 |
| Materna Prep Study Phase II (NCT06126328) | Materna Medical | 2021-09-08 |
| A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial) (NCT04998396) | Aspa Therapeutics | 2021-09-08 |
| The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose (NCT04977479) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-09-08 |
| Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine (NCT04961541) | Novavax | 2021-09-08 |
| Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture (NCT05106517) | Shenzhen People's Hospital | 2021-09-08 |
| A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors (NCT05159388) | Servier Bio-Innovation LLC | 2021-09-08 |
| Hepatocellular Carcinoma Imaging Using PSMA PET/CT (NCT05095519) | Peter MacCallum Cancer Centre, Australia | 2021-09-08 |
| Bacillus Clausii in Liver Transplantation (NCT05047406) | Ain Shams University | 2021-09-07 |
| Phase II/III of Recombinant Human Albumin Injection (NCT06411743) | The First Hospital of Jilin University | 2021-09-07 |
| Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors (NCT04933669) | First Affiliated Hospital of Zhejiang University | 2021-09-07 |
| A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis (NCT05011019) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-09-07 |
| Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection (NCT04838626) | Novartis Pharmaceuticals | 2021-09-07 |
| The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis (NCT04638517) | The University of Queensland | 2021-09-07 |
| Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer (NCT05070598) | Shengjing Hospital | 2021-09-07 |
| Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma (NCT04854499) | Gilead Sciences | 2021-09-07 |
| Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors (NCT05862831) | Biotheus Inc. | 2021-09-07 |
| A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency (NCT04984889) | Takeda | 2021-09-07 |
| Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN (NCT04572854) | Apellis Pharmaceuticals, Inc. | 2021-09-07 |
| Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (NCT05060432) | iTeos Belgium SA | 2021-09-06 |
| A Study of IBI362 in Chinese Patients With Type 2 Diabetes (NCT04965506) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-09-06 |
| Study of WVE-003 in Patients With Huntington's Disease (NCT05032196) | Wave Life Sciences USA, Inc. | 2021-09-06 |
| GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery (NCT04979832) | Zealand University Hospital | 2021-09-06 |
| HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation (NCT05263453) | Shanghai Kechow Pharma, Inc. | 2021-09-06 |
| Evaluate the Safety and Efficacy of Tafasitamab Combined With Lenalidomide in Patients With Relapsed or Refractory DLBCL (NCT05552937) | Beijing InnoCare Pharma Tech Co., Ltd. | 2021-09-06 |
| Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction (NCT04884243) | Cloudbreak Therapeutics, LLC | 2021-09-05 |
| Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer (NCT05299255) | Henan Cancer Hospital | 2021-09-05 |
| Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection (NCT05089305) | Centro Universitario de Ciencias de la Salud, Mexico | 2021-09-04 |
| An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300 to Usual Care (UC) Alone for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Male Emergency Department (ED) Subjects (NCT04996056) | Tonix Pharmaceuticals, Inc. | 2021-09-03 |
| Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas (NCT04883437) | Emory University | 2021-09-03 |
| Hydration Dynamics and Influence of Beverage Composition (NCT05111392) | University of Illinois at Chicago | 2021-09-03 |
| FLX475 in Combination With Ipilimumab in Advanced Melanoma (NCT04894994) | RAPT Therapeutics, Inc. | 2021-09-03 |
| PAIR (Paracetamol and Ibuprofen Research) Pilot Trial (NCT04986839) | Manchester University NHS Foundation Trust | 2021-09-03 |
| SGLT2 Inhibitors in Glomerular Hyperfiltration (NCT04143581) | Mario Negri Institute for Pharmacological Research | 2021-09-03 |
| JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation (NCT05002270) | Jacobio Pharmaceuticals Co., Ltd. | 2021-09-03 |
| Peri-operative SLOG for Localized Pancreatic Cancer (NCT05048524) | National Health Research Institutes, Taiwan | 2021-09-03 |
| Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19 (NCT04932915) | UNION therapeutics | 2021-09-03 |
| Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT (NCT05014594) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-09-03 |
| Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib (NCT04486833) | Genprex, Inc. | 2021-09-03 |
| A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (NCT04537377) | Vivet Therapeutics SAS | 2021-09-03 |
| PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma (NCT03897491) | photonamic GmbH & Co. KG | 2021-09-03 |
| The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients (NCT05168527) | Fudan University | 2021-09-03 |
| A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS (NCT05053035) | Alector Inc. | 2021-09-02 |
| Open-label Study of Surufatinib in Japanese Patients (NCT05077384) | Hutchmed | 2021-09-02 |
| A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis (NCT04990440) | Janssen Research & Development, LLC | 2021-09-02 |
| A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS) (NCT05039099) | AL-S Pharma | 2021-09-02 |
| A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer (NCT05067140) | Novartis Pharmaceuticals | 2021-09-02 |
| Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer (NCT04990921) | University of Louisville | 2021-09-02 |
| Pain After Laparoscopy Results From the Incision, Manipulation of the Abdominal Organs, and Retained CO2(Back Pain) (NCT05186467) | Sohag University | 2021-09-02 |
| The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure (NCT05084235) | Jacob Moller | 2021-09-02 |
| Phase II Study - Trial of a Phototherapy Light Device to Improve Sleep Health (NCT05116358) | University of Arizona | 2021-09-02 |
| Study of INCB086550 in Select Solid Tumors (NCT04629339) | Incyte Corporation | 2021-09-02 |
| The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure (NCT05042973) | Jacob Moller | 2021-09-02 |
| Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) (NCT03597594) | St. Jude Children's Research Hospital | 2021-09-02 |
| Fish Oil (Omega 3 ) in Sjogren's Syndrome (NCT05005806) | Hawler Medical University | 2021-09-02 |
| 3D Printed Titanium Mesh vs Guided Autogenous Graft (NCT05550285) | Mohammed Ghassan Mohammed Shaalan | 2021-09-01 |
| A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma (NCT05007652) | Kyowa Kirin Co., Ltd. | 2021-09-01 |
| Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia (NCT05233124) | Instituto Nacional de Cardiologia Ignacio Chavez | 2021-09-01 |
| A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection (NCT04991688) | University Hospital, Bordeaux | 2021-09-01 |
| A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis (NCT03698448) | AlgiPharma AS | 2021-09-01 |
| Allergic Disease Onset Prevention Study (NCT05003804) | Siolta Therapeutics, Inc. | 2021-09-01 |
| Electrochemotherapy for Recurrent Vulvar Cancer (NCT07443475) | Institute of Oncology Ljubljana | 2021-09-01 |
| Phase II Clinical Trial to Evaluate the Ongoing Pregnancy Rate With OXO-001 in IVF/ICSI With Donor Oocytes. (NCT05076032) | OXOLIFE | 2021-09-01 |
| Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients (NCT05069857) | Shanghai Jiao Tong University School of Medicine | 2021-09-01 |
| Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies (NCT04993885) | Institute of Hematology & Blood Diseases Hospital, China | 2021-09-01 |
| Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer (NCT05034133) | Beijing Haidian Hospital | 2021-09-01 |
| The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT05281068) | Peking University People's Hospital | 2021-09-01 |
| Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19) (NCT05003466) | Shenzhen Kangtai Biological Products Co., LTD | 2021-09-01 |
| A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP (NCT05020288) | Shandong University | 2021-09-01 |
| Azadirachta Indica (Neem) Extract as an Adjunct to Non-Surgical Periodontal Management (NCT06050174) | Ain Shams University | 2021-09-01 |
| Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma (NCT05039606) | Guiyang Medical University | 2021-09-01 |
| Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts (NCT04994444) | Brown University | 2021-09-01 |
| Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma （SPARE-02） (NCT05235100) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-09-01 |
| Evaluation of Safety and Dosing of a Vitamin C Bundle for Sepsis Treatment in Africa (NCT04999137) | Liverpool School of Tropical Medicine | 2021-09-01 |